American News Jul 28, 2021 3:03 PM EST

Pfizer third dose booster shot 'strongly' increases Delta variant protection, data suggests

Earlier this month, the FDA and CDC issued a joint statement on the possibility of a booster shot requirement for immunity against the virus.

Pfizer third dose booster shot 'strongly' increases Delta variant protection, data suggests
Hannah Nightingale Washington DC
Custom made fan favorite Jerseys starting at $24.99
GET STARTED
Custom made fan favorite Jerseys starting at $24.99 with Fansidea

As Delta variant cases of COVID-19 spread across the United States, data released from Pfizer suggests that a booster shot may improve people's immunity against the fast-spreading variant.

In Pfizer's second quarter earnings presentation posted ahead of an earning call, antibody levels after a third dose of the vaccine were reported to be five times higher among people aged 18 to 55 against the Delta variant, and 11 times higher among 65-to-85-year-olds, according to The Hill.

"Emerging real-word data suggests immunity against infection and symptomatic disease may wane," states Pfizer, which demonstrated this in data showing antibodies against the "wild type" and the Beta variant virus waning after eight months from their last dose of the vaccine.

According to Pfizer's presentation, the company would be applying for an Emergency Use Authorization from the Food and Drug Administration as early as August for the booster, with a likely focus on immunocompromised, older adults.

According to The Hill, experts state that antibody levels are not the only measurement of protection from the virus, with other parts of the immune system being activated against the virus.

"Some have noted Pfizer also has a financial incentive to sell more doses of its vaccine to use as boosters," wrote The Hill.

Earlier this month, the FDA and CDC issued a joint statement on the possibility of a booster shot requirement for immunity against the virus.

"Americans who have been fully vaccinated do not need a booster shot at this time. FDA, CDC, and NIH are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary," reads the statement, which adds that while they use data from pharmaceutical companies like Pfizer in their considerations, that data would not be relied upon exclusively.

Ads by revcontent

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial